Aushon Biosystems

Near-term the deal gives Quanterix a CLIA lab while securing technologies that could improve assay multiplexing and support its longer term clinical goals.

As part of the collaboration, RDL has adopted Aushon's technology for simultaneously measuring protein biomarker panels for several autoimmune indications.